It is a privilege to be part of the RiverVest team which has consistently shown the ability to identify impactful technologies and to empower our entrepreneur partners to develop therapies that drastically improve patients’ lives.
As Principal, Isaac conducts diligence on novel investment opportunities while also focusing on deal origination and network development. Isaac also supports the operational activities of current portfolio companies.
Isaac previously served as associate within the Life Sciences practice of the Huron Consulting Group in New York, where he assisted pharmaceutical and biotech clients on strategic projects, ranging from early optimization of R&D processes to commercialization strategies for marketed products.
He earned a Ph.D. in Pharmacology from Vanderbilt University in the lab of Dr. Veenstra-VanderWeele where his thesis work focused on the evaluation and validation of novel animal models for psychiatric disease. He earned a B.S. from the University of Minnesota-Twin Cities, with a double-major in Biochemistry and Genetics, Cell Biology, and Development.